GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » 14-Day RSI

Targeted Medical Pharma (Targeted Medical Pharma) 14-Day RSI : N/A (As of May. 06, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-06), Targeted Medical Pharma's 14-Day RSI is N/A.

The industry rank for Targeted Medical Pharma's 14-Day RSI or its related term are showing as below:

TRGM's 14-Day RSI is not ranked *
in the Drug Manufacturers industry.
Industry Median: 50.915
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Targeted Medical Pharma's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Targeted Medical Pharma's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Targeted Medical Pharma's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Targeted Medical Pharma's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Targeted Medical Pharma's 14-Day RSI falls into.



Targeted Medical Pharma  (OTCPK:TRGM) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Targeted Medical Pharma  (OTCPK:TRGM) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Targeted Medical Pharma 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Targeted Medical Pharma (Targeted Medical Pharma) Business Description

Traded in Other Exchanges
N/A
Address
2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077
Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.
Executives
William B. Horne officer: Chief Financial Officer C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald director C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb director MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph officer: See Remarks C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour director, 10 percent owner, officer: Former President C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher director 12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke officer: Chief Financial Officer C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc 10 percent owner, other: Former 10% Owner 269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel director, officer: Vice President 16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma (Targeted Medical Pharma) Headlines

No Headlines